Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | GILD | JNJ |
|---|
| Close | 147.68 | 267.28 |
| Market Cap | $183B | $644B |
| 1M | +6.31% | +1.87% |
| P/E (TTM) | — | 30.6 |
| Forward P/E | 25.3 | 20.7 |
| P/E 5-Yr Percentile | — | 90 |
| P/S | 6.0 | 6.6 |
| P/B | 15.3 | 7.6 |
| Dividend Yield | 3.98% | 3.12% |
| Latest Quarter Revenue | $7.8B | $25.3B |
| Revenue YoY | +10.2% | +6.6% |
| Gross Margin | 79.8% | 68.2% |
| Latest Quarter EPS | -8.45 | 2.27 |
| Avg Post-Earnings Move | ±3.8% | ±0.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 1.25% |
| 90-Day Net Insider Buying | −$15.4M | −$67.8M |
GILD · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
